Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab bevacizumab alone in women with newly diagnosed advanced ovarian cancer

by Robert Hettle, Charles McCrea, Chee Khoon Lee, Richard Davidson
Published 2021-09-01

When do patient reported quality of life indicators become prognostic in breast cancer?

by Chee Khoon Lee, Malcolm Hudson, John Simes, Karin Ribi, Jürg Bernhard, Alan S. Coates
Published 2018-01-01

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis

by Katrin M. Sjoquist, Sarah J. Lord, Michael L. Friedlander, Robert John Simes, Ian C. Marschner, Chee Khoon Lee
Published 2018-08-01

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology

by Frank P. Lin, Subotheni Thavaneswaran, John P. Grady, Mandy Ballinger, Maya Kansara, Samantha R. Oakes, Jayesh Desai, Chee Khoon Lee, John Simes, David M. Thomas
Published 2021-06-01